Choosing horses for courses: Using liquid agents to embolize endoleaks
It is important to use the right embolic agent for the job
It is important to use the right embolic agent for the job
Vygon, the specialist single-use medical devices group, has acquired Perouse Medical, a French company which designs, manufactures and markets cardiovascular medical devices (stents, vascular grafts and patches, radial compression and inflation systems, hemostasic valves, angiographic syringes as well as consumables for contrast media injectors for CT scanners and MRI, etc.) and long-term vascular access devices (implantable ports, PICCs, Huber needles, catheter maintenance dressings, etc.). Established in 1984, Perouse Medical generated a turnover of
Health care organizations have been implementing health information technology at increasing rates in an effort to engage patients and caregivers improve patient satisfaction, and favourably impact outcomes. A new study led by researchers at Brigham and Women’s Hospital (BWH) finds that a novel web-based, patient-centred toolkit (PCTK) used by patients and/or their healthcare proxys in the hospital setting helped them to engage in understanding and developing their plan of care, and has the potential to improve communication with providers.
The research study, Promoting Respect and Ongoing Safety through Patient-centeredness, Engagement, Communication, and Technology (PROSPECT), provided patients and their caregiver’s iPads on which they could access novel tools to participate in their plan of care during hospitalization. The study was conducted in the medical intensive care and oncology units at BWH. The PCTK provided access to educational content specific to a patient’s condition and facilitated patient-provider communication using a novel messaging platform integrated into providers’ workflow. In this study, researchers evaluated their enrollment strategy, use and usability of patient tools, and the content of patient-generated messages.
‘Doctors and nurses oversee the plan of care, but the patients’ goals, priorities, and preferences may not always be effectively conveyed to the clinical care team. Decision-making should be shared among patients, families and healthcare providers. We found that this tool widened communication, helping patients and family members partner with healthcare providers to improve the quality and safety of their care,’ says lead author Anuj Dalal, MD, and a hospitalist in BWH’s Division of General Medicine and Primary Care.’
Specifically, researchers report that non-critically ill oncology patients were more likely to engage with the PCTK compared with critically-ill MICU patients. However, caregivers of critically-ill MICU patients often used the PCTK on the patient’s behalf. They learned that patients and caregivers most often used the PCTK to establish goals, view test results and medications, and identify care team members. Additionally, patients and caregivers used the messaging functionality primarily to report health concerns, needs, or preferences, but did not overwhelm providers with too many messages or demand immediate responses.
‘Our findings indicate that even with critically-ill patients, technology can serve as a helpful mediator to get the provider, patient and/or caregiver on the same page, working towards a shared goal.’
Researchers indicate that more investigation is needed to better understand how to effectively implement this tool within complex hospital settings, including trouble shooting technological issues, and making the PCTK more user-friendly and accessible for patients and caregivers. Brigham and Woman
Building on wireless technology that has the potential to interfere with pain, scientists have developed flexible, implantable devices that can activate
What happens in the moments just before death is widely believed to be a slowdown of the body
Congenital heart experts from Spectrum Health Helen DeVos Children
How can you tell if someone is depressed? The Diagnostic and Statistical Manual of Mental Disorders (DSM)
A 39-year-old man who had had been completely paralyzed for four years was able to voluntarily control his leg muscles and take thousands of steps in a
University of Queensland researchers have found seven peptides (mini-proteins) in spider venom that block the molecular pathway responsible for sending pain signals from nerves to the brain.
The discovery could inspire a new class of potent painkillers with fewer side effects than current medications.
The research team, led by Professor Glenn King from UQ
A collaboration between biologists and engineers at Monash University has led to the development of a new noninvasive image processing technique to visualize embryo formation. Researchers were able to see, for the first time, the movement of all of the cells in living mammalian embryos as they develop under the microscope. This breakthrough has important implications for IVF (in vitro fertilization) treatments and pre-implantation genetic diagnosis (PGD). In the future, this approach could help with embryo selection before the embryo is implanted back into the uterus to improve IVF success rates.
This latest research provides new insights into embryo formation and challenges the prevailing model of cell placement through division.
Mammalian embryos start out as a small group of identical cells. Then at an early stage, some of these cells take up an internal position within the embryo. These internal cells are the ones that will go on to form all of the cells of the body while the remaining outer cells go on to form other tissues such as the placenta.
For many years, researchers theorized that the internal cells adopt their position through a special process of cell division, but due to technological limitations, this had never actually been shown. Using their newly developed imaging methods, the Monash University researchers were able to demonstrate that this model of embryo formation was incorrect.
The researchers then applied cutting-edge laser techniques to the mammalian embryo (previously used in fly and plant embryos or cultured cells only) to determine what forces were acting on the cells to make them move inside the embryo.
Using these new imaging techniques, researchers were able to see how the cells moved and changed shape over time as they were
April 2024
The medical devices information portal connecting healthcare professionals to global vendors
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com
PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.
This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.
Accept settingsHide notification onlyCookie settingsWe may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.
Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.
These cookies are strictly necessary to provide you with services available through our website and to use some of its features.
Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.
We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.
We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.
.These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.
If you do not want us to track your visit to our site, you can disable this in your browser here:
.
We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page
Google Webfont Settings:
Google Maps Settings:
Google reCaptcha settings:
Vimeo and Youtube videos embedding:
.U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.
Privacy policy